AFT Pharmaceuticals reports FY17 loss but sees return to profit on the horizon

AFT Pharmaceuticals reports FY17 loss but sees return to profit on the horizon
Rebecca Howard
By Rebecca Howard May 24 (BusinessDesk) - AFT Pharmaceuticals, which manufactures the Maxigesic painkiller, reported a full-year loss in the year to March 31 but expects to significantly narrow those deficits this year and return to profitability in the 2018/19 period. The company reported a net loss of $18.4 million, or 19 cents per share, in the 12 months ended March 31, from a loss of $13.3 million, or 48 cents per share, in the prior year. Operating revenue rose to $69.2 million, meeting guidance and up from $64 million in the prior y...